Corcept Therapeutics, Inc. (CORT) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $113.35 --0%
EPS Growth %: +393.8%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
PMCB, PLCE, DOMO, More
EPS Growth %: +393.8%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Corcept Therapeutics, Inc. (NASDAQ: CORT) reported Q1 EPS of ($0.11), $0.02 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $4.41 million versus the consensus estimate of $5.01 million.
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley upgrades Robinhood, sees 43% upside
- Protagonist Therapeutics (PTGX) PT Raised to $170 at H.C. Wainwright
- Chipotle Mexican Grill (CMG) PT Raised to $53 at BofA Securities
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
